Yuli Qian

Zhejiang International Studies University

Also affiliated with AbbVie (United States), Women's Hospital, School of Medicine, Zhejiang University

Pharmacology, Toxicology and PharmaceuticsMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation”.

Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01399-23

N/A

0DataRank · unranked

21 citations

Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolomé Moyá +13 more

Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes

Nature Medicine(2025)10.1038/s41591-025-03984-1

N/A

0DataRank · unranked

25 citations

Shigang Zhao, Yanzhi Du, Ziyi Yang, Ye Tian, Junli Zhao +54 more